Researchers at The Institute of Medical Science, The University of Tokyo play a global role in understanding SARS-CoV-2 and COVID-19 and share their mission of contributing to saving the lives of people.
Publications
PLATINUM STREET TIMES：Public relation magazine of IMSUT
The special feature : Research on SARS-CoV-2 and COVID-19. *only in Japanese
Tansei vol.41 2020.09：UTokyo's Official Magazine
*only in Japanese
Press Releases (Latest three releases)
July 14,2023
High Body Temperature Increases Resistance to Pathogenic Viral Infections, New Study Finds
Representative : Associate Professor ICHINOHE Takeshi at the Division of Viral Infection
March 15, 2023
New Study Shows SARS-CoV-2 Omicron XBB.1.5 Variant is Highly Transmissible and Infectious
Representative : Professor SATO Kei at the Division of Systems Virology
March 7, 2023
Scientists Suggest Guidelines to Prevent SARS-CoV-2 Transmission from Deceased Individuals
Representative : Professor KAWAOKA Yoshihiro at the Division of Virology
Scientific Papers (Latest three papers)
Transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA.2.86 variantThe Lancet Infectious Diseases (online) September 18,2023
doi:10.1016/S1473-3099(23)00575-3
Keiya Uriu#, Jumpei Ito#, Yusuke Kosugi, Yuri L Tanaka, Yuka Mugita, Ziyi Guo, Alfredo HINAY, Jr, Olivia Putri, Yoonjin Kim, Ryo Shimizu, MST Monira Begum, Michael Jonathan, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Akatsuki Saito, Terumasa Ikeda, Kei Sato*.
（#Equal contribution; *Corresponding author）
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against Omicron subvariants including EG.5
The Lancet Infectious Diseases (online) September 11,2023
doi:10.1016/S1473-3099(23)00553-4
Yu Kaku#, Yusuke Kosugi#, Keiya Uriu#, Jumpei Ito#, Alfredo A Hinay Jr., Jin Kuramochi, Kenji Sadamasu, Kazuhisa Yoshimura, Hiroyuki Asakura, Mami Nagashima, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato*.
（#Equal contribution; *Corresponding author）
In vitro and in vivo characterization of SARS-CoV-2 resistant to ensitrelvir
Nature Communications (online) July 15,2023
doi:10.1038/s41467-023-40018-1
Maki Kiso*, Seiya Yamayoshi¶, Shun Iida, Yuri Furusawa, Yuichiro Hirata,
Ryuta Uraki, Masaki Imai, Tadaki Suzuki, Yoshihiro Kawaoka¶
*:First author
¶:Corresponding author
Research Support Information
AMED Research Projects on COVID-19https://www.amed.go.jp/en/program/list/11/02/002_covid-19.html
■Diagnosis
FY2020
Project Title：Precision and portable diagnostics for viruses with new genome editing technology
Principal Investigator：Senior Assistant Professor YOSHIMI Kazuto at the Division of Animal Genetics
■Therapeutics
FY2020
Project Title：Studies to Control Emerging, Re-emerging and Imported Infectious Diseases to Be Conducted in International Collaboration Sites in China
Principal Investigator：Professor KAWAGUCHI Yasushi at the Research Center for Asian Infectious Diseases
FY2020
Project Title：Establishment of the antibody therapy against novel coronavirus disease (COVID-19)
Principal Investigator：Professor KAWAOKA Yoshihiro at the Division of Virology
■Vaccine
FY2019
Project Title：Study on the control of a novel coronavirus (2019-nCoV)
Principal Investigator：Professor KAWAOKA Yoshihiro at the Division of Virology
FY2020
Project Title：Development of a live attenuated vaccine against COVID-19
Principal Investigator：Professor KAWAOKA Yoshihiro at the Division of Virology
FY2020
Project Title：Development of a live attenuated vaccine against COVID-19 II
Principal Investigator：Professor KAWAOKA Yoshihiro at the Division of Virology
■Scientific Research on COVID-19
FY2020
Project Title：Investigation of the biological principle of the pathogenicity and cross-species transmission of emerging virus infections including SARS-CoV-2
Principal Investigator：Associate Professor SATO Kei at the Division of Systems Virology
FY2020
Project Title：Antibody response against SARS-CoV-2 infection and serosurveillance
Principal Investigator：Project Associate Professor YAMAYOSHI Seiya at Research Center for Asian Infectious Diseases